Gilead, Cognizant
Cognizant Expands Partnership with Gilead
Gilead is expected to enhance its efficiency through leveraging Cognizant’s expertise in AI and advanced technology applications. By deploying these solutions across the value chain, Cognizant aims to help Gilead achieve significant benefits through a newly optimized financial framework.
Cognizant and Gilead Expand Partnership to Drive Greater Value Through Advanced Technology Applications
Cognizant (NASDAQ: CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (NASDAQ: GILD) that aims to unlock even greater value for Gilead as it advances innovations to prevent and treat life-threatening diseases.
TEANECK, N.J. - Cognizant Technology Solutions Corporation (NASDAQ:CTSH), a prominent player in the IT Services industry with ...
The testimony of Srimanikandan Ramamoorthy, dubbed the essential witness by the US Department of Justice, is critical, ...
Cognizant sued Infosys, accusing it of stealing secrets related to its US subsidiary TriZetto's healthcare insurance software ...
Members of the Alphabet Workers Union had challenged the National Labor Relations Board's decision to only order Google to ...
A new AI development framework and services are said to fast track multi-agent adoption by enabling interoperability and scalability to transform business processes.
Cognizant released a study on young consumers’ increased use of AI, and discussed how that will impact designing AI systems ...
Get the latest updates on the company's financial performance, strategic acquisitions, and market shifts. Explore detailed ...
Cognizant Technology Solutions Corporation (NASDAQ:CTSH) stock has reached a 52-week high, touching $82.48 in a notable uptick that reflects investor confidence in the company's growth trajectory.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback